Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evolution Of Growth Rate In Children With Growth Retardation Related To Long-term Corticotherapy And Treated By Genotonorm

NCT00163189 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00163189
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00163189 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evolution Of Growth Rate In Children With Growth Retardation Related To Long-term Corticotherapy And Treated By Genotonorm
Lead sponsor
Pfizer
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2005
Completion date
December 31, 2014
Enrollment
98 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

growth hormone deficiency